Valedictory Function of the National Pharmacovigilance Week 2026

The Valedictory Function of the National Pharmacovigilance Week 2026 was held at Jubilee Mission Medical College and Research Institute, Thrissur, marking the conclusion of a week-long series of sensitization programs, outreach activities, and creative initiatives dedicated to the theme “Promoting Rational Use Of Medicines Through Pharmacovigilance: A Step Towards Safer Healthcare.”

The event began with a prayer, setting a reflective tone for the afternoon. Dr. Maria Jose, Professor and Head of the Department of Pharmacology, delivered the welcome address, extending gratitude to the management, faculty, and all departments that had actively contributed to the success of the Pharmacovigilance Week.

The Valedictory Address was delivered by Dr. M. A. Andrews, Principal of JMMC & RI, who commended the Pharmacovigilance Committee for its dynamic and inclusive approach to promoting ADR reporting and medication safety. He emphasized that true vigilance arises from consistent learning, honest observation, and teamwork among healthcare providers. Dr. Andrews congratulated the organizing team for aligning institutional efforts with the broader national mission of the PvPI and encouraged everyone to sustain the spirit of reporting beyond the celebration week.

Following this, Dr. Gitty Thimothy, Clinical Pharmacist, presented the National Pharmacovigilance Week Activities Report 2026, summarizing the week’s diverse activities— from hospital-based sensitization sessions for doctors, nurses, and house surgeons, to external awareness programs at Vimala college and a Workshop on Pharmacovigilance at Mother Hospital, Thrissur, as well as creative events such as “EXP℞ESSIONS”. Her report captured the enthusiasm of participants and the impact of each initiative in strengthening the institution’s ADR monitoring culture.

A short video presentation showcasing the highlights of the National Pharmacovigilance Week 2026 followed, evoking a sense of pride and shared purpose among the audience.

The prize distribution ceremony recognized the artistic and educational contributions made during the EXP℞ESSIONS competition. Fr. Terin Mullakkara, Assistant Director, presented the prizes to the first, second, and third-place winners for their innovative artworks

Dr. Shibu C. Kallivalappil, Medical Superintendent, presented the prizes to the first, second, and third-place winners of the quiz competition conducted for House Surgeons.

A special prize was awarded for the best Slogan writing competition conducted for nursing students, and the prize was presented by Dr. Padmakumar K, Vice Principal.

Achievements secured by department members in the National Pharmacovigilance Week were also highlighted during the session. The gathering was then addressed by Dr. Shibu C. Kallivalappil, Medical Superintendent, during the felicitation segment. He praised the Pharmacovigilance Committee’s efforts to blend science with creativity and community participation, applauding the inclusive engagement of students, doctors, and allied health professionals in promoting medication safety.

The Pharmacovigilance Newsletter 2026 was formally released by Dr. Shibu C. Kallivalappil, documenting the year’s key achievements, departmental contributions, and success stories in ADR reporting from the Jubilee Mission AMC. The release symbolized the continuation of dialogue and learning beyond the week’s celebrations.

The function concluded with the vote of thanks delivered by Dr. Sanitha Kuriachan, Professor, Department of Pharmacology. Dr. Sanitha expressed heartfelt gratitude to the principal, management, faculty, and all participants for their enthusiastic support, while extending special appreciation to the organizing team, student volunteers, and technical staff who ensured the smooth conduct of every event.

The Valedictory Function thus drew the National Pharmacovigilance Week 2026 to a meaningful close — celebrating vigilance, collaboration, and creativity, and reaffirming Jubilee Mission’s enduring commitment to patient safety through continuous pharmacovigilance.

Share This Story, Choose Your Platform!

Share This Story,